Ads
related to: Novavax Vaccine
Search results
Novavax’s R&D head, integral to Covid vaccine work, to retire - Washington Business Journal
The Business Journals· 4 days agoThe head of research and development at Novavax Inc., a key player in the development of its...
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks via Yahoo Finance· 6 days agoZacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing...
Smart Money Is Betting Big In NVAX Options - Novavax (NASDAQ:NVAX)
Benzinga· 5 days agoThe company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly ...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 3 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 5 days agoThe three vaccines updated to target the SARS-CoV-2 XBB.1.5 subvariant -- Moderna's and Pfizer-BioNTech's mRNA vaccines and the Novavax
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 4 days agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...
Growth Stocks to Avoid Like the Plague: 3 Overpriced Picks Primed to Plummet
InvestorPlace· 2 days agoGrowth stocks can be millionaire-makers and the same ideas can be destroyers of wealth. The...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 3 days agoThe authors said the findings underscore the need for new boosters. Next week, the Center for...
5 stocks that are back from the dead
Financial Post via Yahoo Finance· 4 days agoThe stock was US$3 earlier this year. But in May, Sanofi SA showed up out of the blue and gave Novavax a US$1.4-billion licensing deal to develop a combo...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 4 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
